SOPHiA Genetics is the creator of a global data pooling and knowledge-sharing platform that advances data-driven medicine, working with customers from more than 780 institutions in more than 70 countries. The goal of this data-driven medicinal network is to improve health outcomes and economics worldwide. On July 22, SOPHiA Genetics announced the pricing of its initial public offering (Nasdaq: SOPH) of 13 million ordinary shares at $18 per share . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post Creating a Clinical Crystal Ball: SOPHiA Genetics is Democratizing Data-Driven Medicine appeared first on GEN – Genetic Engineering and Biotechnology News.